These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 17979800)
1. Sphingolipid signaling pathways as potential therapeutic targets in gliomas. Van Brocklyn JR Mini Rev Med Chem; 2007 Oct; 7(10):984-90. PubMed ID: 17979800 [TBL] [Abstract][Full Text] [Related]
2. Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate. Hawkins CC; Ali T; Ramanadham S; Hjelmeland AB Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32977496 [TBL] [Abstract][Full Text] [Related]
3. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells. Marfia G; Campanella R; Navone SE; Di Vito C; Riccitelli E; Hadi LA; Bornati A; de Rezende G; Giussani P; Tringali C; Viani P; Rampini P; Alessandri G; Parati E; Riboni L Glia; 2014 Dec; 62(12):1968-81. PubMed ID: 25042636 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response. Sordillo LA; Sordillo PP; Helson L Anticancer Res; 2016 May; 36(5):2085-95. PubMed ID: 27127108 [TBL] [Abstract][Full Text] [Related]
5. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis. Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321 [TBL] [Abstract][Full Text] [Related]
6. Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme. Bien-Möller S; Lange S; Holm T; Böhm A; Paland H; Küpper J; Herzog S; Weitmann K; Havemann C; Vogelgesang S; Marx S; Hoffmann W; Schroeder HW; Rauch BH Oncotarget; 2016 Mar; 7(11):13031-46. PubMed ID: 26887055 [TBL] [Abstract][Full Text] [Related]
7. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. Van Brocklyn JR; Williams JB Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819 [TBL] [Abstract][Full Text] [Related]
8. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159 [TBL] [Abstract][Full Text] [Related]
9. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. Huwiler A; Pfeilschifter J Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766 [TBL] [Abstract][Full Text] [Related]
10. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Kihara A; Mitsutake S; Mizutani Y; Igarashi Y Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104 [TBL] [Abstract][Full Text] [Related]
11. Sphingolipids in neurodegeneration (with focus on ceramide and S1P). Wang G; Bieberich E Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225 [TBL] [Abstract][Full Text] [Related]
13. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity. Tabuchi K; Hara A Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830 [TBL] [Abstract][Full Text] [Related]
14. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders. Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333 [TBL] [Abstract][Full Text] [Related]
15. Targeting the Sphingolipid Rheostat in Gliomas. Zaibaq F; Dowdy T; Larion M Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012521 [TBL] [Abstract][Full Text] [Related]